UNSPSC 51341503: Foscarnet

This classification denotes a reverse transcriptase inhibitor with the molecular formula CH3O5P, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 364P9RVW4X, chemically known as phosphinecarboxylic acid, dihydroxy-, oxide but generally known as foscarnet, which bears US NIH Compound Identifier 3415. European Medicines Agency schedules Foscarnet in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02258MIG.

World Health Organization schedules foscarnet in its Anatomical Therapeutic Chemical (ATC) Classification. As of Q4 2014, FOSCARNET remains the US FDA Preferred Term for this commodity. Foscarnet bears US NLM identifiers UMLS ID C0070895 and NCI Concept Code C71630. SMILES: P(=O)(O)(O)C(=O)O.

UNSPSC 51341503 Foscarnet, a Commodity code, does not align with the recent state and local solicitation activity tagged under it. The two opportunities posted in the source — a completed pharmaceutical warehouse piggyback award through the Illinois Department of Public Health for Doxycycline Hyclate and Ciprofloxacin Hydrochloride, and a Seminole County, Florida procurement for Naloxone and drug deactivation systems — involve antibiotics and opioid-reversal medications rather than Foscarnet, an antiviral agent for cytomegalovirus treatment. The mismatch suggests either a tagging error in the state and local procurement database or that foscarnet procurement activity remains below the threshold of recent posted opportunities.

No open solicitations for Foscarnet or related antiviral pharmaceutical products appear in the source. The Illinois Department of Public Health and Seminole County are the only issuing bodies named, but their recent activity falls outside the code's nominal scope. Without active solicitations or awarded contracts specifically targeting foscarnet or functionally equivalent antivirals, the code shows little actionable signal for business development purposes at this time.